Cargando…
Development of monoclonal antibodies and quantitative ELISAs targeting insulin-degrading enzyme
BACKGROUND: Insulin-degrading enzyme (IDE) is a widely studied zinc-metalloprotease implicated in the pathogenesis of type 2 diabetes mellitus, Alzheimer disease (AD) and varicella zoster virus infection. Despite more than six decades of research on IDE, progress has been hampered by the lack of wel...
Autores principales: | DelleDonne, Anthony, Kouri, Naomi, Reinstatler, Lael, Sahara, Tomoko, Li, Lilin, Zhao, Ji, Dickson, Dennis W, Ertekin-Taner, Nilufer, Leissring, Malcolm A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768702/ https://www.ncbi.nlm.nih.gov/pubmed/19835587 http://dx.doi.org/10.1186/1750-1326-4-39 |
Ejemplares similares
-
Insulin-degrading enzyme is exported via an unconventional protein secretion pathway
por: Zhao, Ji, et al.
Publicado: (2009) -
Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound Screening
por: Cabrol, Christelle, et al.
Publicado: (2009) -
Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin
por: Leissring, Malcolm A., et al.
Publicado: (2010) -
Insulin-Degrading Enzyme: Paradoxes and Possibilities
por: Leissring, Malcolm A.
Publicado: (2021) -
Identification of BACE2 as an avid ß-amyloid-degrading protease
por: Abdul-Hay, Samer O, et al.
Publicado: (2012)